DEXCOM INC is 16.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($28.85 B vs $1.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PLSE | DXCM |
|---|---|---|
| Market cap | $1.73 B | $28.85 B |
| US-listed rank | #2199 | #473 |
| Revenue (latest FY) | $350.00K | $4.66B |
| Net income (latest FY) | -$72.78M | $836.30M |
| Net margin | -20794.6% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 616 | 2,566 |
DEXCOM INC is 16.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($28.85 B vs $1.73 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while DEXCOM INC reported $4.66B.
Full pages: Pulse Biosciences, Inc. and DEXCOM INC, or browse the full rankings.